Skip to content

Distributed Registry

Distributed Registry Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03898570
Enrollment
100
Registered
2019-04-02
Start date
2019-04-01
Completion date
2021-03-01
Last updated
2023-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, Cardiovascular Diseases, Intermittent Claudication, Patient Compliance, Peripheral Arterial Disease, Peripheral Vascular Diseases, Signs and Symptoms, Vascular Diseases

Brief summary

The purpose of this study is to test if a patient can be directly connected to a quality assurance (QA) database, traditionally known as a registry. Patient-reported outcomes (PRO) data will be entered into the database directly from a patient's mobile phone from their index procedure for 12 months. The investigators hope this study to be a proof of concept for such a distributed registry and evaluate 1) consistency of data acquisition, 2) engagement of patients, 3) overall value of patient-reported outcomes to enhance long term follow up.

Interventions

BEHAVIORALPatient reported outcomes

Patients will download the research app onto their phone and enter pertinent medical history and surgical history data similar to standard registries for specific procedures. Over the next 12 months the investigators will obtain patient-reported outcomes (PROs) using the patient's phone. Specifically, the investigators will obtain daily activity data, weekly 6-minute-walk tests, and quarterly quality of life surveys

Sponsors

AstraZeneca
CollaboratorINDUSTRY
Stanford University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Patients with cardiovascular disease who are scheduled or have undergone either a) open or endovascular vascular procedure, or b) open or percutaneous cardiac procedure. 2. Patients with smartphones (iOS or Android) with unlimited data plans. 3. Patients who agree to remote surveillance

Exclusion criteria

1. Patients unwilling to download a research study app. 2. Data plans which are not unlimited.

Design outcomes

Primary

MeasureTime frameDescription
Patient Reported Outcomes (PROs) using mobile app1 YearPROs are any report of the status of a patient's health condition that comes directly from the patient, without interpretation of the patient's response by a clinician or anyone else

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026